Clinical Trials Logo

Clinical Trial Summary

DOSCORT is a 2-dose, cross-over study primarily aiming to identify and validate novel biological markers (biomarkers) of glucocorticoid effect in the human body. Patients with Addison´s disease, primary adrenal insufficiency, with life-long glucocorticoid replacement therapy will undergo 2 treatment periods where their usual hydrocortisone treatment will be replaced with betamethasone in physiological and supra physiological doses. Blood, saliva, urine, health related Quality-of-life self-assessment forms, measurements of physical activity and sleep quality will be collected from both treatment periods.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03210545
Study type Interventional
Source Göteborg University
Contact Johanna Mc Queen, MD
Phone 0046313428588
Email johanna.mcqueen@gu.se
Status Recruiting
Phase Phase 4
Start date March 2, 2021
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT02152553 - Biomarker(s) for Glucocorticoids N/A
Completed NCT02096510 - Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia Phase 1/Phase 2
Enrolling by invitation NCT04789993 - Additional Autoimmune Diseases With Type 1 Diabetes in Pediatrics at Diabetes Diagnosis and During Follow-up
Unknown status NCT01847690 - Effect of Cortisol on Physical Exertion in Patients With Primary Adrenal Failure Phase 2
Recruiting NCT04374721 - Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders N/A
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed NCT00251836 - Adrenal Function After Living Kidney Donation N/A
Completed NCT03941184 - Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Recruiting NCT05515055 - Does Relative Hypoglycaemia &/or Sleep Disturbance Contribute to the Lethargy Observed in Addison's Disease
Terminated NCT01840189 - Continuous Subcutaneous Hydrocortisone Infusion In Addison's Disease and Type 1 Diabetes Phase 2
Completed NCT01271296 - Effects and Interactions of Liquorice and Grapefruit on Glucocorticoid Replacement Therapy in Addison's Disease N/A